- Medicine Name: Vonjo
- Generic Name: Pacritinib
- Dosage Form & Strength: It comes as Capsules: 100 mg
- Manufactured By: CTI BioPharma Corp
Vonjo is a kinase inhibitor indicated for the treatment of adults with intermediate or high-risk primary or secondary myelofibrosis (post-polycythemia vera or post-essential thrombocythemia) when they have a platelet count below 50 x 10^9/L. This indication is granted under accelerated approval based on spleen volume reduction. Continued approval may be contingent upon verification of clinical benefit in confirmatory trials.
- Recommended dosage: 200 mg orally twice daily.
- May be taken with or without food.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.